16.01.2026
35th Challenge in Infectious Diseases, 16 - 17 January 2026
Engelberg, Kursaal
The Annual Infectious Disease Symposium has been replaced by monthly virtual lunch sessions and the Special Session at the SSI Annual Meeting.
2026
2025
17.01.2025
34th Challenge in Infectious Diseases, 17 - 18 January 2025
Engelberg, Kursaal
Registration closed
169 participants
Programme, as of January 13, 2025
Jenal U: Pseudomonas aeruginosa breaches respiratory epithelia
Rybniker J: Discovery of highly neutralizing human antibodies targeting Pseudomonas aeruginosa
Clardy J: Mining of the human microbiome for antimicrobial peptide discovery
Didierlaurent A: New vaccine technologies for immunocompromised populations
Maertens K: Prevention by vaccination in pregnant women
Moline H: Pediatric RSV Epidemiology and New Prevention Product Use in the U.S.
Arts R. J. W.: Trained immunity and its role in health and disease
Pittet L: Trained immunity in practice: BCG and risk of infectious diseases
Bargetzi A: Bizarre illness: Fever with unfolding hepatitis
Weller D: Traces obscuring the vision
Sia-Herren C: Insidious back pain and scrotal swelling
Brahier Th: Another bizzare case from Lausanne
L'Huilier A: Increasing immunosuppression: will it save or kill my patient?
Kirchhoff F: Virus-guided CRISPR/Cas9 screens identify novel antiviral factors and mechanisms
Paiardini M: Leveraging the SIV Model to Assess Immunotherapy-Based Cure Interventions
Finzi A: Exploiting HIV-1 Env conformation for clinical intervention
Koopmans M: One Health, climate change and emerging viruses
Greub G: Tick-borne infections: recent discoveries and future research opportunities
Harris E: Friend and Foe: Explaining the complex epidemiology and epidemiology of dengue and Zika viruses
Herrera Carrillo E: CRISPR-based HIV cure strategies
Lei Qi St: Precision CRISPR tools for SARS-CoV-2 and broad-spectrum respiratory RNA virus targeting
Eckerle I: Emerging zoonotic viruses - what’s next?
Hilty M: One-health approach to investigate AMR dissemination
Jenal U: Pseudomonas aeruginosa breaches respiratory epithelia
Rybniker J: Discovery of highly neutralizing human antibodies targeting Pseudomonas aeruginosa
Clardy J: Mining of the human microbiome for antimicrobial peptide discovery
Didierlaurent A: New vaccine technologies for immunocompromised populations
Maertens K: Prevention by vaccination in pregnant women
Moline H: Pediatric RSV Epidemiology and New Prevention Product Use in the U.S.
Arts R. J. W.: Trained immunity and its role in health and disease
Pittet L: Trained immunity in practice: BCG and risk of infectious diseases
Bargetzi A: Bizarre illness: Fever with unfolding hepatitis
Weller D: Traces obscuring the vision
Sia-Herren C: Insidious back pain and scrotal swelling
Brahier Th: Another bizzare case from Lausanne
L'Huilier A: Increasing immunosuppression: will it save or kill my patient?
Kirchhoff F: Virus-guided CRISPR/Cas9 screens identify novel antiviral factors and mechanisms
Paiardini M: Leveraging the SIV Model to Assess Immunotherapy-Based Cure Interventions
Finzi A: Exploiting HIV-1 Env conformation for clinical intervention
Koopmans M: One Health, climate change and emerging viruses
Greub G: Tick-borne infections: recent discoveries and future research
opportunities
Harris E.: Friend and Foe: Explaining the complex epidemiology and epidemiology of dengue and Zika viruses
Herrera Carrillo E: CRISPR-based HIV cure strategies
Lei Qi St: Precision CRISPR tools for SARS-CoV-2 and broad-spectrum respiratory RNA virus targeting
Eckerle I: Emerging zoonotic viruses - what’s next?
Hilty M: One-health approach to investigate AMR dissemination
2024
28.08.2024
SAFE-ID Special Session
Kursaal Bern
17:30-18:30
Frederic Lamoth, CHUV: Update on Candida auris: from bench to bedside
Salome LeibundGut, Zurich University: Fungal commensalism in homeostasis and disease
2023
13.09.2023
SAFE-ID Special Session @ Annual Meeting SSI
Kongresshaus Zürich
17:30 - 19:00
Registration: Closed
60 participants
Judith Allen: Type 2 cytokines in helminth immunity & Tissue repair
Jan-Willem Veening: A conserved antigen induces protection against pneumococcal superinfection
Followed by aperitif
16.03.2023
Disease heterogeneity in COVID-19: an interferon paradox?
Virtual lunch session
12:00-12:45
Registration closed
98 participants
Disease heterogeneity in COVID-19: an interferon paradox?
16.02.2023
Drug resistant tuberculosis: a scientific update
Virtual lunch session
12:00-12:45
Registration closed
110 participants
Drug resistant tuberculosis: a scientific update
Nicolas Veziris, Sorbonne Université, Assistance Publique Hôpitaux de Paris
Moderator: Johannes Nemeth, Zurich University Hospital
19.01.2023
Monkeypox - Where are we now?
Virtual lunch session
12:00-12:45
Registration closed
127 participants
Monkeypox - Where are we now?
2022
21.09.2022
SAFE-ID Special Session @ Annual Meeting SSI
17:30-20:30, Interlaken
followed by rich aperitif
Registration closed
120 Participants
Programme as of August 14, 2022
2021
18.03.2021
42nd Annual Infectious Diseases Symposium
Bern
Cancelled due to COVID-19
Will be replaced by monthly virtual meetings. Information to follow.
2020
19.03.2020
42nd Annual Infectious Diseases Symposium
Bern, Inselspital
Auditorium Maurice E. Müller
Freiburgstrasse 16
Programme as of February 27, 2020
Hot topic: Coronavirus SARS-CoV-2
Cancelled due to COVID-19
Credits 6 CME
Angela Huttner; Antibiotic therapy duration: shortest is beautiful
Ondrej Mach; The polio end game
Silvio Brugger; The nose knows
Sarah Tschudin; Metronidazole for C. difficile: Pro/con
Nicolas Noël; Immune checkpoint inhibitors and infections
Shamez Ladhani; Experience with meningococcal group B
Vetter Pauline, Koch Daniel, Kuster Stefan: Coronavirus SARS-CoV-2: Impact global and local
Angela Huttner; Antibiotic therapy duration: shortest is beautiful
Ondrej Mach; The polio end game
Silvio Brugger; The nose knows
Sarah Tschudin; Metronidazole for C. difficile: Pro/con
Nicolas Noël; Immune checkpoint inhibitors and infections
Shamez Ladhani; Experience with meningococcal group B
vaccination programme
Vetter Pauline, Koch Daniel, Kuster Stefan: Coronavirus SARS-CoV-2: Impact global and local
2019
21.03.2019
41st Annual Infectious Diseases Symposium
Zürich, Careum Auditorium
Pestalozzistrasse 11
8032 Zürich
158 participants, incl 9 faculty
Programme as of March 12, 2019
Adrian Egli; Future of diagnostic microbiology
Marc J. M. Bonten; Antibiotic cycling and mixing: Can we influence antibiotic resistance rates?
Pauline Paterson; Vaccine hesitancy
Ron Dagan; Pneumococcal immunization: successes and challenges for the next decade
Steven Holland; Innate immunodeficiencies
Pauline Vetter; Ebola: past and present
Future of diagnostic microbiology - Adrian Egli
Antibiotic cycling and mixing: Can we influence antibiotic resistance rates? - Marc J. M. Bonten
Vaccine hesitancy - Pauline Paterson
Pneumococcal immunization: successes and challenges for the next decade - Ron Dagan
2018
15.03.2018
40th Annual Infectious Diseases Symposium
Zürich
Careum Auditorium
Pestalozzistrasse 11
8032 Zürich
173 participants, incl 7 faculty
Programme as of March 8, 2018
Registration closed
Credits: 5 CME by SSI, SGIM, SSP/SGP, FAMH and other societies
Treating multi-resistant gram negative bacteria; J Rodríguez-Baño
Plague in Madagascar: epidemiology in changing environments; S Telfer
PrEP efficacy and risk compensation; J-M Molina
Burden of influenza in the elderly; J McElhaney
Clinical metagenomics: why does microbiota matter?; J Schrenzel - slides not available
2017
23.03.2017
39th Annual Infectious Diseases Symposium
Lucerne
168 participants, incl 27 faculty
How to treat Staphylococcal bacteremia/endocarditis in 2017, Josep M. Miró
Human genomics of immune response, Ch. Hammer
Etiology of Community Acquired Pneumonia: current concepts, Daniel M. Musher
2016
31.03.2016
38th Annual Infectious Diseases Symposium
Lucerne
181 participants, incl 19 faculty
Programme updated Mar 29, 2016
Turning on the heat on bacteria in the nasopharynx - Christoph M. Tang
New insights in the pathogenesis of Listeria - Marc Lecuit
The burden of rickettsiosis - the perspective from Asia - Daniel H. Paris
The threat of KPC producting bacteria - Yehuda Carmeli
The human virome: where are we? - Laurent Kaiser
Zika virus - Case presentations - not available
2015
2014
- Page
- 1